KR900005970A - 파괴성 치근막 질환을 치료하는 방법 및 조성물 - Google Patents

파괴성 치근막 질환을 치료하는 방법 및 조성물 Download PDF

Info

Publication number
KR900005970A
KR900005970A KR1019890014325A KR890014325A KR900005970A KR 900005970 A KR900005970 A KR 900005970A KR 1019890014325 A KR1019890014325 A KR 1019890014325A KR 890014325 A KR890014325 A KR 890014325A KR 900005970 A KR900005970 A KR 900005970A
Authority
KR
South Korea
Prior art keywords
composition
carrier
dichloro
physiologically acceptable
methylphenylamino
Prior art date
Application number
KR1019890014325A
Other languages
English (en)
Inventor
드간트 클라크 제이알. 죠세프
테오도르 메이어스 이반
세이어 콘맨 켄네쓰
칼 홀드 스탠리
Original Assignee
토마스 디.몰리터노
워너-램버트 컴패니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 토마스 디.몰리터노, 워너-램버트 컴패니 filed Critical 토마스 디.몰리터노
Publication of KR900005970A publication Critical patent/KR900005970A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Abstract

내용 없음

Description

파괴성 치근막 질환을 치료하는 방법 및 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 온혈 동물의 치육 조직을 효과량의 2-(2,6-디클로로-3-매틸페닐아미노)벤조산이나 이것의 생리학적으로 허용가능한 염과 접촉시키는 것으로 구성된, 온혈 동물의 파괴성 치근막 질환을 치료하는 방법.
  2. 제1항에 있어서, 2-(2,6-디클로로-3-메틸페닐아미노)벤조산이나 이것의 생리학적으로 허용가능한 염이 국소적으로 투여가능한 제약학적 조성물로 치육 조직에 직접 투여되는 방법.
  3. 제1항에 있어서, 2-(2,6-디클로로-3-메틸페닐아미노)벤조산이나 이것의 생리학적으로 허용가능한 염이 구강내에 투여 및 방출되어 구강의 치육조직과 접촉하게 되는 방법.
  4. 2-(2,6-디클로로-3-메틸페닐아미노)벤조산이나 이것의 생리학적으로 허용가능한 염을 치육조직과의 국소적 접촉에 대해 온혈 동물의 치육 조직에 또는 이것의 주변에 공급할 수 있는생리학적으로 허용가능한 담체와 함께 효과량의 2-(2,6-디클로로-3-메틸페닐아미노)벤조산이나 이것의 생리학적으로 허용가능한 염으로 구성된, 온혈 동물의 파괴성 치근막 질환을 치료하는 조성물.
  5. 제4항에 있어서, 담체가 수성 부형제인 조성물.
  6. 제4항에 있어서, 담체가 겔 베이스(gel base)인 조성물.
  7. 제4항에 있어서, 담체가 치약이나 치분 제제인 조성물.
  8. 제4항에 있어서, 담체가 로젠지인 조성물.
  9. 제4항에 있어서, 담체가 식료품인 조성물.
  10. 제4항에 있어서, 담체가 씹는 껌 제제인 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890014325A 1988-10-06 1989-10-05 파괴성 치근막 질환을 치료하는 방법 및 조성물 KR900005970A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US254526 1988-10-06
US07/254,526 US4933172A (en) 1988-10-06 1988-10-06 Method of and compositions for treating destructive periodontal disease

Publications (1)

Publication Number Publication Date
KR900005970A true KR900005970A (ko) 1990-05-07

Family

ID=22964617

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890014325A KR900005970A (ko) 1988-10-06 1989-10-05 파괴성 치근막 질환을 치료하는 방법 및 조성물

Country Status (17)

Country Link
US (1) US4933172A (ko)
EP (1) EP0367382B1 (ko)
JP (1) JPH02145516A (ko)
KR (1) KR900005970A (ko)
AT (1) ATE85520T1 (ko)
AU (1) AU615110B2 (ko)
DE (1) DE68904872T2 (ko)
DK (1) DK491689A (ko)
ES (1) ES2054005T3 (ko)
FI (1) FI894710A (ko)
GR (1) GR3007246T3 (ko)
IE (1) IE893207L (ko)
NO (1) NO893970L (ko)
NZ (1) NZ230902A (ko)
PH (1) PH27264A (ko)
PT (1) PT91906B (ko)
ZA (1) ZA897596B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5230895A (en) * 1990-05-01 1993-07-27 Copley Pharmaceutical Inc. Sustained released delivery system for use in the periodontal pocket
US5318960A (en) * 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances
US5807541A (en) * 1996-04-22 1998-09-15 Sepracor, Inc. NSAID/fluoride periodontal compositions and methods
IT1291278B1 (it) * 1996-07-05 1999-01-07 Errekappa Euroterapici S P A Preparazione farmaceutica a base di nimesulide per uso topico
US5792446A (en) * 1997-02-18 1998-08-11 Collagenex Pharmaceuticals, Inc. Delivery system for administering dentin-hypersensitivity-ameliorating compositions
IT1291895B1 (it) * 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
IT1315274B1 (it) * 1999-12-29 2003-02-03 Cip Ninety Two 92 Sa Composizioni farmaceutiche per la somministrazione localizzata nelcavo orale di farmaci antiinfiammatori non stereoidei utili per la
US20040077609A1 (en) * 2001-01-16 2004-04-22 Michael Rubin Oral composition containing NSAIDs and essential oils
US20050226821A1 (en) * 2002-02-22 2005-10-13 Jacob Waugh Cosmetic formulations containing l-arginine oligomers
CN1738613A (zh) * 2002-11-18 2006-02-22 细胞基因公司 包含(+)－3－(3,4－二甲氧基－苯基)－3－(1－氧代－1,3－二氢－异吲哚－2－基)－丙酰胺的组合物及其使用方法
EP1811944B1 (en) 2004-11-16 2010-09-08 3M Innovative Properties Company Compositions including a caseinate treated dental filler

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4722938A (en) * 1984-12-26 1988-02-02 Analgesic Associates Methods for using musculoskeletal relaxants
US4780463A (en) * 1984-12-26 1988-10-25 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
IT1216233B (it) * 1986-07-02 1990-02-22 Menarini Sas Utilizzazione della forma farmaceutica 'gel'contenente acido n (2,6 dicloro m tolil) antranilico (acido meclofenamico) impiegabile in terapia per uso topico.
US4843099A (en) * 1987-07-20 1989-06-27 Colgate-Palmolive Company Device and composition for treatment of the gums

Also Published As

Publication number Publication date
ATE85520T1 (de) 1993-02-15
NZ230902A (en) 1991-11-26
PT91906B (pt) 1995-05-31
DE68904872T2 (de) 1993-06-17
FI894710A0 (fi) 1989-10-05
GR3007246T3 (ko) 1993-07-30
NO893970L (no) 1990-04-09
EP0367382A1 (en) 1990-05-09
PH27264A (en) 1993-05-04
ZA897596B (en) 1990-07-25
FI894710A (fi) 1990-04-07
ES2054005T3 (es) 1994-08-01
IE893207L (en) 1990-04-06
JPH02145516A (ja) 1990-06-05
AU4247789A (en) 1990-04-12
NO893970D0 (no) 1989-10-05
AU615110B2 (en) 1991-09-19
US4933172A (en) 1990-06-12
DK491689D0 (da) 1989-10-05
DK491689A (da) 1990-04-07
DE68904872D1 (de) 1993-03-25
EP0367382B1 (en) 1993-02-10
PT91906A (pt) 1990-04-30

Similar Documents

Publication Publication Date Title
KR900005970A (ko) 파괴성 치근막 질환을 치료하는 방법 및 조성물
ATE69160T1 (de) Verwendung von usninsaeure oder deren derivaten bei der behandlung von zahnfaeule.
PL292865A1 (en) Mouth care lotion for preventing dental calculus formation
DE69228922D1 (de) Dentin desensibilisierende Mittel
JPH0597668A (ja) 歯周炎の治療
FI77370C (fi) Neutral natriumfluoridgel foer lokalt bruk.
DE69016665D1 (de) Orales s(+)-flurbiprofen- oder ketoprofenhaltiges mittel.
SE7810158L (sv) Infrarodstralningskommunikationssystem
JP2009522343A (ja) 口臭治療におけるモルホリノ化合物の使用
SE8900915L (sv) Tandvaardsmedel
JPS61293909A (ja) 口腔内組成物
Gaffar Oral-care products
KR960016875A (ko) 이부 프로펜을 함유한 치약 조성물
JPS57126413A (en) Composition for oral cavity
TH2679EX (th) วิธีการต่อต้านคราบฟันและต่อต้าเหงือกอักเสบโดยใช้กรดโพลีฟอสโฟนิคบางตัว
TH3942EX (th) สารผสมสำหรับใช้ในปากเพื่อต่อต้านหินปูน

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid